Epsilon-entropy in preclinical elements of syntropic clusters from tables of personalized diagnostics and prognosis

In this work, the author, for the first time, enables physicians to gain knowledge about developing diseases that are in the preclinical stage in the syntropic cluster of each person. This will, for the first time, give physicians the opportunity to manage diseases and ensure secondary prevention, where there will be no therapeutic agents necessary for one disease, but contraindicated for others 1. Calculating the epsilon-entropy of these forms of disease will, for the first time, allow us to identify among preclinical diseases those that have either stopped or slowed down in their development, or, conversely, to identify those that are ready to manifest clinically in the near future.